Showing results (91-100 of 108) with videos related to
Sort By:
Pageof 11
Nature Medicine|February 9, 2021
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)Alexander M Menzies, Rodabe N Amaria, Elisa A Rozeman, et al.Cancer Cell|December 24, 2021
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordanceFelicity Newell, Ines Pires da Silva, Peter A Johansson, et al.The Journal of Experimental Medicine|March 15, 2023
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanomaIrene L M Reijers, Disha Rao, Judith M Versluis, et al.European Journal of Cancer (Oxford, England : 1990)|November 27, 2024
Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neoIrene L M Reijers, Alexander M Menzies, Marta Lopez-Yurda, et al.Nature Medicine|September 22, 2022
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiomeRebecca C Simpson, Erin R Shanahan, Marcel Batten, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2020
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III MelanomaLauren E Haydu, Serigne N Lo, Jennifer L McQuade, et al.Journal for Immunotherapy of Cancer|March 25, 2025
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanomaLi Zhou, Milton Jose Barros E Silva, Edward Hsiao, et al.Nature Communications|October 17, 2020
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversityFelicity Newell, James S Wilmott, Peter A Johansson, et al.Cancer Discovery|September 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma SubtypesFelicity Newell, Peter A Johansson, James S Wilmott, et al.JAMA Dermatology|April 9, 2025
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous MelanomaSerigne N Lo, Caroline Gjorup, Annette Hougaard Chakera, et al.Pageof 11